Roche Navigation Menu Roche Online : Roche Online
  • Einloggen
  • Ausloggen
  • Language: FR
  • Suche
Roche
  • Zurück
  • Home
  • fr
  • Search
  • Close search

						
							

Searching

    • Home
    • Medizinische Informationen
      Medizinische Informationen Übersicht
      • Hämatologie
      • Neurologie
      • Onkologie
      • Ophthalmologie
      Spotlight Medikationssicherheit

      Medikationssicherheit

    • Produkte
      Produkte Übersicht
      • Onkologie
      • ALECENSA® (Alectinib)
      • AVASTIN® (Bevacizumab)
      • COTELLIC® (Cobimetinib) | Zelboraf® (Vemurafenib)
      • Erivedge® (Vismodegib)
      • GAVRETO® (Pralsetinib)
      • Herceptin® (Trastuzumab)
      • Kadcyla® (Trastuzumab Emtansin)
      • MabThera® (Rituximab)
      • Perjeta® (Pertuzumab)
      • PHESGO® (Pertuzumab-Trastuzumab)
      • TECENTRIQ® (Atezolizumab)
      • ROZLYTREK® (Entrectinib)
      • Hämatologie
      • Gazyvaro® (Obinutuzumab)
      • HEMLIBRA® (Emicizumab)
      • POLIVY® (Polatuzumab Vedotin)
      • Neurologie
      • ENSPRYNG® (Satralizumab)
      • Evrysdi® (Risdiplam)
      • OCREVUS® (Ocrelizumab)
      • Pneumologie
      • Esbriet® (Pirfenidon)
      • Rheumatologie
      • ACTEMRA® (Tocilizumab)
      • Ophthalmologie
      • VABYSMO® (Faricimab)
    • Kongresse & News
      Kongresse & News Übersicht
    • Informationsmaterial
      Informationsmaterial Übersicht
    • Für Pflegefachpersonen
      Für Pflegefachpersonen Übersicht
    • Apps
      Apps Übersicht
    • Home
    • Medizinische Informationen
      • Hämatologie
      • Neurologie
      • Onkologie
      • Ophthalmologie
    • Produkte
      • Onkologie
        • ALECENSA® (Alectinib)
        • AVASTIN® (Bevacizumab)
        • COTELLIC® (Cobimetinib) | Zelboraf® (Vemurafenib)
        • Erivedge® (Vismodegib)
        • GAVRETO® (Pralsetinib)
        • Herceptin® (Trastuzumab)
        • Kadcyla® (Trastuzumab Emtansin)
        • MabThera® (Rituximab)
        • Perjeta® (Pertuzumab)
        • PHESGO® (Pertuzumab-Trastuzumab)
        • TECENTRIQ® (Atezolizumab)
        • ROZLYTREK® (Entrectinib)
      • Hämatologie
        • Gazyvaro® (Obinutuzumab)
        • HEMLIBRA® (Emicizumab)
        • POLIVY® (Polatuzumab Vedotin)
      • Neurologie
        • ENSPRYNG® (Satralizumab)
        • Evrysdi® (Risdiplam)
        • OCREVUS® (Ocrelizumab)
      • Pneumologie
        • Esbriet® (Pirfenidon)
      • Rheumatologie
        • ACTEMRA® (Tocilizumab)
      • Ophthalmologie
        • VABYSMO® (Faricimab)
    • Kongresse & News
    • Informationsmaterial
    • Für Pflegefachpersonen
    • Apps
    • Einloggen
    • Ausloggen
    Schließen

    1 - of Resultate zu: ""

    No results

     

    Unser Portal ist ausschliesslich zugänglich für medizinisches Fachpersonal.

    Seit 2010 fordert Swissmedic den Zugriffsschutz für pharmazeutische Websites mit Fachwerbung für Arzneimittel.

     

    Bitte hier registrieren

    Privacy notices in relation to interactions

     

    As part of our interactions with you, we would like to give you an overview of how we process your personal data. What specific personal data are processed and used depends largely on the services requested or agreed in each case. 

    The responsible person for data processing is Roche Pharma (Switzerland) Ltd, Gartenstrasse 9, CH-4052 Basel, Email: switzerland.dataprivacy@roche.com. Please contact the address given if you have any questions.

    What sources do we use

    We collect and process personal data that you have voluntarily provided to us directly in a personal conversation or, for example, by registering for an e-newsletter or congress, which we have obtained from a specialist address provider or from publicly accessible sources (e.g. websites).

    What we process your data for

    We process personal data for the following purposes:

    To fulfil contractual obligations 

    Personal data are processed for the execution of contracts with you or for the performance of pre-contractual measures. Further details on the purpose of data processing can be found in the respective contractual documents and terms and conditions. The purposes of data processing primarily depend on the specific product and may include, among other things, needs analyses, consulting as well as market and opinion research.

    To interact and communicate with you

    First and foremost, we process data such as your contact details, email address or details of your profession for the purposes of administrative management and in connection with our business activities, so as to be able to provide you with optimum support, to contact you in a targeted manner and to send you information that is relevant to you. This also includes, for example, your opinion of our services, products and therapeutic areas, your interest in further training or in a medical/scientific collaboration. In certain circumstances, personal data can only be processed if you have given us your prior consent, such as in the context of direct marketing for the sending of email newsletters. You can revoke your consent at any time. Please note that the revocation is only effective for the future.

    To comply with legal requirements

    As a pharmaceutical company, we are subject to various legal obligations, including accounting, transparency and documentation obligations. In particular, we are subject to legal documentation and reporting obligations for suspected adverse reactions in connection with drug safety.

    If data are processed by third parties and disclosed across borders

    To the extent necessary for the purposes mentioned above, we disclose your data, including across borders, to other Roche Group companies that use your personal data for the same purpose as we do, as well as to service providers commissioned by us (including Roche Group companies and market research agencies, IT service providers, for example) in Switzerland, the EU and in some circumstances also outside the EU. The processing of personal data by commissioned service providers is transferred in compliance with legal requirements by contractual agreement. We remain responsible for this data processing. 

    How long are data stored 

    We store personal data only as long as is necessary for the purpose for which they were collected or as long as required under applicable laws and regulations. As a rule, we store your data for a further 10 years after the end of the business relationship and then delete them. 

    How we protect your data

    Roche uses technology and safeguards to protect your personal information from unauthorised access, improper use, disclosure, loss or destruction. Your data are only accessible to authorised persons who need them because of their duties and responsibilities. 

    Rights

    You have the right to obtain information about the personal data stored about you, and you may also request that your data be corrected or deleted, or that processing be restricted. To exercise your rights, or if you have any questions, please contact us at: switzerland.dataprivacy@roche.com.

     

      • Datenschutzhinweise in Bezug auf Interaktionen
      • Privacy notices in relation to interactions
      • Notification de confidentialité relative aux interactions
      • Indicazioni sulla protezione dei dati riguardo alle interazioni
      • Datenschutzerklärung
      • La protection des données personnelles
      • Protezione di dati personali
      • Privacy Policy

    • © 2023 © 2021 Roche Pharma (Schweiz) AG, 4052 Basel
    • 27.09.2022
    • Impressum
    • Datenschutzerklärung
    • Rechtliche Hinweise
    • Cookie settings

    Diese Website ist ausschliesslich für in der Schweiz ansässige Benutzer bestimmt und kann Produktdetails oder Produktinformationen enthalten, die in Ihrem Land nicht verfügbar sind oder nicht gültig sind. Bitte beachten Sie, dass Roche Pharma (Schweiz) AG keine Verantwortung für den Zugang zu solchen Informationen übernimmt, die unter Umständen nicht mit den jeweils gültigen gesetzlichen Vorgehensweisen, Regelungen, Registrierungen oder Gepflogenheiten in Ihrem Land übereinstimmen. Die Roche Pharma (Schweiz) AG ist ein Unternehmen der F. Hoffmann-La Roche AG.